EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) price on Thursday, July 03, rose 0.62% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $9.72.
A look at the stock’s price movement, the close in the last trading session was $9.66, moving within a range at $9.63 and $10.02. The beta value (5-Year monthly) was 1.639. Turning to its 52-week performance, $13.98 and $3.91 were the 52-week high and 52-week low respectively. Overall, EYPT moved 19.70% over the past month.
EyePoint Pharmaceuticals Inc’s market cap currently stands at around $668.85 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EYPT is a 100% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend EYPT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EYPT’s current price about 5.98% and 28.38% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 62.47, while 7-day volatility ratio is 6.97% and 7.75% in the 30-day chart. Further, EyePoint Pharmaceuticals Inc (EYPT) has a beta value of 1.76. Analysts have given the company’s stock an average 52-week price target of $26, forecast between a low of $22 and high of $30. Looking at the price targets, the low is -126.34% off current price level while to achieve the yearly target high, price needs to move -208.64%. Nonetheless, investors will most likely welcome a -167.49% jump to $26 which is the analysts’ median price.
If we refocus on EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), historical trading data shows that trading volumes averaged 0.88 over the past 10 days and 848.38K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.81 million shares.
The 13.08% of EyePoint Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 96.93% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.74 million on 2025-06-13, giving us a short ratio of 7.29. The data shows that as of 2025-06-13 short interest in EyePoint Pharmaceuticals Inc (EYPT) stood at 1174.0 of shares outstanding, with shares short falling to 7.21 million registered in 2025-05-15. Current price change has pushed the stock 16.97% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EYPT stock continues to rise going into the next quarter.
